This tool has been developed for urologists, oncologists, specialist nurses, specialist pharmacists, pathologists and radiologists. The recommendations for discharge to primary care may be of interest to GPs.
To examine the NICE guideline recommendations for bladder cancer and to apply the knowledge you’ve gained to practice. This e-learning tool will take you about 1 hour to complete if you work through all the sections.
The NICE clinical guideline 2 is the first to focus uniquely on bladder cancer. Bladder cancer is the seventh most common cancer in the UK. It is 3-4 times more common in men than women. The main risk factor for bladder cancer is increasing age.
This e-learning tool helps you implement the NICE guideline and identify key changes for practice. The tool considers information and support for people with bladder cancer, diagnosis, staging and risk classification of bladder cancer. You will also work though case studies and activities about treating non-muscle-invasive and muscle-invasive bladder cancer.